Implantable cardioverter-defibrillator therapy in primary versus secondary prevention: Reliable prediction of appropriate therapies and mortality is still an unmet need

• Yukiomi Tsuji,
• Dobromir Dobrev

Affiliations

Yukiomi Tsuji

Department of Physiology of Visceral Function and Body Fluid, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan; Corresponding author at: 1-12-4 Sakamoto, Nagasaki 852-8523, Japan.

Dobromir Dobrev

Institute of Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Essen, Germany